Unknown

Dataset Information

0

Design of Monovalent and Chimeric Tetravalent Dengue Vaccine Using an Immunoinformatics Approach.


ABSTRACT: An immunoinformatics technique was used to predict a monovalent amide immunogen candidate capable of producing therapeutic antibodies as well as a potent immunogen candidate capable of acting as a universal vaccination against all dengue fever virus serotypes. The capsid protein is an attractive goal for anti-DENV due to its position in the dengue existence cycle. The widely accessible immunological data, advances in antigenic peptide prediction using reverse vaccinology, and the introduction of molecular docking in immunoinformatics have directed vaccine manufacturing. The C-proteins of DENV-1-4 serotypes were known as antigens to assist with logical design. Binding epitopes for TC cells, TH cells, and B cells is predicted from structural dengue virus capsid proteins. Each T cell epitope of C-protein integrated with a B cell as a templet was used as a vaccine and produce antibodies in contrast to serotype of the dengue virus. A chimeric tetravalent vaccine was created by combining four vaccines, each representing four dengue serotypes, to serve as a standard vaccine candidate for all four Sero groups. The LKRARNRVS, RGFRKEIGR, KNGAIKVLR, and KAINVLRGF from dengue 1, dengue 2, dengue 3, and dengue 4 epitopes may be essential immunotherapeutic representatives for controlling outbreaks.

SUBMITTER: Dixit NK 

PROVIDER: S-EPMC8475484 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10838208 | biostudies-literature
| S-EPMC229366 | biostudies-literature
| S-EPMC7362859 | biostudies-literature
| S-EPMC8492693 | biostudies-literature
| S-EPMC8397861 | biostudies-literature
| S-EPMC5686733 | biostudies-literature
| S-EPMC6392503 | biostudies-literature
| S-EPMC114964 | biostudies-literature
| S-EPMC10690774 | biostudies-literature
| S-EPMC8675112 | biostudies-literature